Evolutionary Genomics (FNAM) Price & Analysis

1 Followers

FNAM Stock Chart & Stats

$0.45

$0.00(0.00%)

At close: Oct 31 4:00 PM EDT

$0.45

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.45 - $0.45

Previous CloseN/A

Volume1.00K

Average Volume (3M)N/A

Market Cap

$1.33K

Enterprise Value$3.17M

Total Cash (Recent Filing)$577.07K

Total Debt (Recent Filing)$3.74M

Price to Earnings (P/E)―

Beta-1.16

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.29

Shares Outstanding6,655,232

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio0.07

Price to Book (P/B)-2.87

Price to Sales (P/S)0.00

P/FCF Ratio-7.01

Enterprise Value/Market Cap2.38K

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit-4.26

Enterprise Value/Ebitda-3.19

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

FNAM FAQ

What was Evolutionary Genomics Inc’s price range in the past 12 months?

Evolutionary Genomics Inc lowest stock price was $0.45 and its highest was $0.45 in the past 12 months.

What is Evolutionary Genomics Inc’s market cap?

Evolutionary Genomics Inc’s market cap is $1.33K.

When is Evolutionary Genomics Inc’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Evolutionary Genomics Inc’s earnings last quarter?

Evolutionary Genomics Inc released its earnings results on May 15, 2018. The company reported -$0.06 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.06.

Is Evolutionary Genomics Inc overvalued?

According to Wall Street analysts Evolutionary Genomics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Evolutionary Genomics Inc pay dividends?

Evolutionary Genomics Inc does not currently pay dividends.

What is Evolutionary Genomics Inc’s EPS estimate?

Evolutionary Genomics Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Evolutionary Genomics Inc have?

Evolutionary Genomics Inc has 6,655,232 shares outstanding.

What happened to Evolutionary Genomics Inc’s price movement after its last earnings report?

Evolutionary Genomics Inc reported an EPS of -$0.06 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.

Which hedge fund is a major shareholder of Evolutionary Genomics Inc?

Currently, no hedge funds are holding shares in FNAM

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Evolutionary Genomics Inc

Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.